← SynDRA
ACIPIMOX
SynDRA canonical compound SYN0005110 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | HCAR2 |
|---|
| Mechanism of action | cholesterol inhibitor |
|---|
| Indication | hyperlipidemia |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- HCAR2 FULL AGONIST
- cholesterol inhibitor
- HCAR2 AGONIST
Drug classes
- Antimetabolites
- Hypolipidemic Agents
- Lipid Regulating Agents
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
Cross-references
Synonyms
- olbemox
- olbetam
- methylpyrazinecarboxylic acid 4-oxide
- NSC-759818
- Olbetam
- Monted
- Nedios
- Olbemox
- K 9321
- 5-Carboxy-2-methylpyrazine 1-oxide
- 5-METHYLPYRAZINE-2-CARBOXYLIC ACID-4-OXIDE
- 5-Methylpyrazinecarboxylic acid 4-oxide
- 5-methyl-4-oxidopyrazin-4-ium-2-carboxylic acid
- 2-CARBOXY-5-METHYLPYRAZINE 4-OXIDE
- K-9321
- CHEMBL345714
- NCGC00160519-01
- 5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid
- CAS-51037-30-0
- SR-05000001505
- 5-Methyl-2-pyrazinecarboxylic acid 4-oxide
- Acipimox-[d4]
- MFCD00865757
- Acipimox (INN/BAN)
- ACIPIMOX [INN]
- ACIPIMOX [MI]
- Pyrazinecarboxylic acid, 5-methyl-, 4-oxide
- ACIPIMOX [MART.]
- K9AY9IR2SD
- ACIPIMOX [WHO-DD]
- SCHEMBL48922
- GTPL1596
- DTXSID2046202
- CHEBI:94688
- HMS2090G05
- HMS3655A14
- HMS3713L18
Look up ACIPIMOX in the interactive SynDRA portal →